Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-25-009112

Director gave up 16,875 shares (to pay taxes)

  • Director acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Abecassis Michael M · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-12 Grant or award : show line 1 in the form +37,500 39,167 D
2025-12-12 Shares withheld for taxes : show line 2 in the form −16,875 $1.02 $17,213 22,292 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-25 Grant or award : show line 3 in the form Stock Option (Right to Buy) +63,233 63,233 D
Loading xslF345X05/ownership.xml…